Telocinobufagin inhibits the epithelial-mesenchymal transition of breast cancer cells through the phosphoinositide 3-kinase/protein kinase B/extracellular signal-regulated kinase/Snail signaling pathway

Telocinobufagin (TBG), an active ingredient of Venenumbufonis, exhibits an immunomodulatory activity. However, its antimetastatic activity in breast cancer remains unknown. The present study investigated whether TBG prevents breast cancer metastasis and evaluated its regulatory mechanism. TBG inhibi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Gao, Yuxue, Shi, Lihong, Cao, Zhen, Zhu, Xuetao, Li, Feng, Wang, Ruyan, Xu, Jinyuan, Zhong, Jinyi, Zhang, Baogang, Lu, Shijun
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2018
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5920466/
https://ncbi.nlm.nih.gov/pubmed/29725474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8349
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars